{
    "nct_id": "NCT04716699",
    "official_title": "Assessing Systemic and Local Levels of Lidocaine During Surgery for Glioblastoma",
    "inclusion_criteria": "* >= 18 years of age\n* Preoperative imaging characteristics consistent with brain glioblastoma (magnetic resonance imaging [MRI] brain)\n* Patients who are undergoing neurosurgical resection for treatment of glioblastoma\n* Ability to understand and willingness to sign an informed consent form\n* Ability to adhere to the study visit schedule and other protocol requirements\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior treatment for glioblastoma\n* Glioblastoma size less than 5 cm^3\n* Known allergy against amide type of local anesthetics\n* History of severe cardiac failure (determined by clinical history of less the 3 Metabolic Equivalent of Tasks [METs])\n* 2nd or 3rd degree heart block (exception: patients with pacemaker)\n* Concurrent treatment with class I or III antiarrhythmics (phenytoin, procainamide, propranolol, quinidine) or amiodarone use =< 3 months\n* History of Wolff-Parkinson-White syndrome, Stokes Adams syndrome, or active dysrhythmia\n* History of bradycardia\n* Prior clinical history of severe hepatic impairment or alanine aminotransferase (ALT) and aspartate aminotransferase (AST) greater than 1.55 times of upper normal limit\n* Prior clinical history of severe renal impairment or estimated glomerular filtration rate (EGFR) < 30ml/min\n* Uncontrolled seizure disorder\n* Acute porphyria\n* Patients requiring an awake fiberoptic intubation due to administration of additional lidocaine\n* Pregnant or lactating women\n* Any condition that would prohibit the understanding or rendering of informed consent\n* Any medical condition including additional malignancies, laboratory abnormalities, or psychiatric illness that in the opinion of the investigator would prevent the subject from participating and adhering to study related procedures\n* Uncontrolled concomitant disease that in the opinion of the investigator would interfere with the patient's safety or compliance on trial",
    "miscellaneous_criteria": ""
}